entospharma

Entos Pharmaceuticals develops next-generation nucleic acid-based therapies using their proprietary Fusogenix drug delivery system. The company focuses on the advancement of innovative therapeutic solutions designed to improve patient outcomes and address unmet medical needs within the pharmaceutical industry.

Services include:
- Development of nucleic acid-based therapies
- Drug delivery system services
- Research and development partnerships
- Regulatory support

Entospharma is dedicated to providing cutting-edge solutions that drive the future of medicine. For more information, please visit entospharma.com.